Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogota, Colombia

被引:30
|
作者
Parra, Eliana L. [1 ]
De La Hoz, Fernando [2 ]
Diaz, Paula L. [1 ]
Sanabria, Olga [1 ]
Elena Realpe, Maria [1 ]
Moreno, Jaime [1 ]
机构
[1] Inst Nacl Salud, Grp Microbiol, Bogota, Colombia
[2] Univ Nacl Colombia, Bogota, Colombia
关键词
Streptococcus pneumoniae serotypes; Nasopharyngeal carriage; Pneumococcal conjugate vaccine; UNITED-STATES; EARLY IMPACT; CHILDREN; COLONIZATION; REPLACEMENT; POPULATION; DISCOVERY; ERA;
D O I
10.1016/j.vaccine.2013.04.074
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: In Bogota, the Heptavalent Conjugate Vaccine (PCV7) was introduced into childhood immunization schedule since 2009. The aim of this study was to assess the changes in serotype distribution and penicillin susceptibility of Streptococcus pneumoniae isolates recovered from nasopharyngeal samples and invasive disease among children living in Bogota, before and after PCV7 introduction. Methods: Nasopharyngeal swabs were collected from healthy children aged between 12 and 18 months of age before (years 2005-2006) and after (2011) PCV7 introduction. Identification of S. pneumoniae was performed by multiplex PCR. Serotype was determined by PCR and Quellung reaction. Susceptibility to penicillin, ceftriaxone, trimethoprim-sulfamethoxazole, chloramphenicol, tetracycline and erythromycin was evaluated. In addition, distribution of serotypes and antimicrobial susceptibility before and after vaccine introduction among invasive isolates recovered from children <= 2 years old living in Bogota was analyzed. Results: Prevalence of pneumococcal nasopharyngeal carriage declined from 55.7% (137/246) in unvaccinated to 44.2% (87/197) (p = 0.01) in vaccinated children. The proportion of children carrying PCV7 serotypes decreased from 23.6% (58/246) to 7.6% (15/197) (p < 0.001). The decrease was counterbalanced by an increase in the proportion of non-PCV7 serotypes. The most prevalent among emerging serotypes were 15A, 15B, 15 C, 11A and 35B. Among IPD isolates, PCV7 serotypes decreased from 69.1% (235/340) in 2005/2009 to 38.0% (32/84) in 2010/2011 (p < 0.001). The increase of non-PCV7 serotypes was significant. Resistance to penicillin among invasive isolates recovered from meningitis decreased from 41.1% (30/73) in the pre-vaccine period to 14.2% (2/14) in post-vaccine period (p = 0.02). Conclusions: A decrease in the prevalence of pneumococcal nasopharyngeal carriage following the introduction of PCV7 vaccine, have been overshadowed by an important surge in the prevalence of non-PCV7 serotypes. Systematic surveillance combining nasopharyngeal carriage surveys and IPD detection could help in evaluating the impact of conjugate vaccines. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:4033 / 4038
页数:6
相关论文
共 50 条
  • [11] Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine
    Lee, Joon Kee
    Yun, Ki Wook
    Choi, Eun Hwa
    Kim, Sun Jung
    Lee, Seong Yeon
    Lee, Hoan Jong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (09) : 1431 - 1439
  • [12] Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Bulgaria before the introduction of pneumococcal conjugate vaccine
    Setchanova, L. P.
    Alexandrova, A.
    Mitov, I.
    Nashev, D.
    Kantardjiev, T.
    JOURNAL OF CHEMOTHERAPY, 2012, 24 (01) : 12 - 17
  • [13] Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
    Melegaro, Alessia
    Choi, Yoon Hong
    George, Robert
    Edmunds, W. John
    Miller, Elizabeth
    Gay, Nigel J.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [14] Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
    Alessia Melegaro
    Yoon Hong Choi
    Robert George
    W John Edmunds
    Elizabeth Miller
    Nigel J Gay
    BMC Infectious Diseases, 10
  • [15] Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine
    Mera, Robertino
    Miller, Linda A.
    Fritsche, Thomas R.
    Jones, Ronald N.
    MICROBIAL DRUG RESISTANCE, 2008, 14 (02) : 101 - 107
  • [16] Nasopharyngeal Carriage of Streptococcus pneumoniae Among Young Children in Haiti Before Pneumococcal Conjugate Vaccine Introduction
    Watkins, Louise K. Francois
    Milucky, Jennifer L.
    McGee, Lesley
    St-Surin, Florence Sine
    Liu, Pengbo
    Tran, Theresa
    Chochua, Sopio
    Joseph, Gerard
    Shang, Nong
    Juin, Stanley
    Dely, Patrick
    Patel, Roopal
    Van Beneden, Chris A.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 : S248 - S257
  • [17] Temporal changes in nasopharyngeal carriage of Streptococcus pneumoniae serotype 1 genotypes in healthy Gambians before and after the 7-valent pneumococcal conjugate vaccine
    Ebruke, Chinelo
    Roca, Anna
    Egere, Uzochukwu
    Darboe, Ousainou
    Hill, Philip C.
    Greenwood, Brian
    Wren, BrendanW.
    Adegbola, Richard A.
    Antonio, Martin
    PEERJ, 2015, 3
  • [18] Effect of the introduction of the pneumococcal conjugate vaccine on invasive disease produced by Streptococcus pneumoniae
    Cercenado, E.
    Cuevas, O.
    Fenoll, A.
    Marin, M.
    Vicioso, D.
    Bouza, E.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S294 - S294
  • [19] Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine
    Perez-Trallero, E.
    Marimon, J. M.
    Ercibengoa, M.
    Vicente, D.
    Perez-Yarza, E. G.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (07) : 731 - 738
  • [20] Pediatric osteoarticular infections caused by Streptococcus pneumoniae before and after the introduction of the heptavalent pneumococcal conjugate vaccine
    Lemaitre, C.
    Ferroni, A.
    Doit, C.
    Vu-Thien, H.
    Glorion, C.
    Raymond, J.
    Mary, P.
    Wicart, P.
    Bingen, E.
    Ilharreborde, B.
    Lorrot, M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (10) : 2773 - 2781